Neurosense Therapeutics Ltd (NRSN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,196 | N/A | -4,041 | 0 | -2,828 |
| Depreciation Amortization | 41 | N/A | 3 | 0 | 3 |
| Accounts receivable | -397 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 86 | N/A | N/A | N/A | N/A |
| Other Working Capital | -311 | N/A | 273 | 0 | 69 |
| Other Operating Activity | 2,491 | 0 | 2,226 | 0 | 2,061 |
| Operating Cash Flow | $-4,286 | $N/A | $-1,539 | $0 | $-695 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -6,000 | N/A | N/A | N/A | N/A |
| PPE Investments | -30 | N/A | -17 | 0 | -9 |
| Purchase Of Investment | -19 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-6,049 | $N/A | $-17 | $0 | $-9 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,870 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -163 | 0 | 11,902 | 0 | 508 |
| Financing Cash Flow | $3,707 | $N/A | $11,902 | $0 | $508 |
| Exchange Rate Effect | -86 | N/A | 18 | 0 | 0 |
| Beginning Cash Position | 11,063 | N/A | 699 | 0 | 895 |
| End Cash Position | 4,349 | N/A | 11,063 | 0 | 699 |
| Net Cash Flow | $-6,714 | $N/A | $10,364 | $0 | $-196 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,286 | N/A | -1,539 | 0 | -695 |
| Capital Expenditure | -30 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -4,316 | 0 | -1,539 | 0 | -695 |